...
首页> 外文期刊>Metabolism: Clinical and Experimental >Serum cholesterol efflux potential in postmenopausal monkeys treated with tibolone or conjugated estrogens.
【24h】

Serum cholesterol efflux potential in postmenopausal monkeys treated with tibolone or conjugated estrogens.

机译:用替勃龙或结合雌激素治疗的绝经后猴子的血清胆固醇外流潜能。

获取原文
获取原文并翻译 | 示例
           

摘要

Tibolone is a synthetic steroid used for the treatment of climacteric symptoms and the prevention of osteoporosis, but the effect on the cardiovascular system is unclear since tibolone lowers high-density lipoprotein (HDL) levels. We investigated if long-term treatment with tibolone or conventional hormone replacement therapy (HRT) in cynomolgus monkeys could affect their serum cholesterol efflux potential. Surgically postmenopausal cynomolgus monkeys were treated for 2 years with conjugated equine estrogens (CEE), CEE plus medroxyprogesterone acetate (MPA), low-dose tibolone, or high-dose tibolone. Plasma lipid, lipoprotein, and apolipoprotein levels were monitored during the study. The cholesterol efflux potential of the serum from each animal was determined in (3)H-cholesterol-labeled Fu5AH cells and skin fibroblasts in culture. Tibolone induced a dose-dependent 30% to 52% reduction in HDL levels. When HDL concentrations were reduced by 30%, as seen in women, there was no reduction in the serum cholesterol efflux potential in Fu5AH cells. With a 52% reduction in HDL, there was a 14% reduction in cholesterol efflux. Although CEE or CEE+MPA had no significant effect on HDL levels, CEE treatment increased serum cholesterol efflux potential by 7%. With the same sera, no changes in cholesterol efflux were seen with fibroblasts. Although our findings suggest that HDL concentration is correlated with cholesterol efflux potential of serum, this relationship is weak, explaining only 16% of the variability. This is emphasized by the fact that despite a 30% lowering of HDL with tibolone, there was no indication of an adverse effect on cellular cholesterol efflux. Other changes in the serum not measured in this study must contribute significantly to the cholesterol efflux potential of serum. Because changes in cholesterol efflux potential of serum were seen only in Fu5AH cells, a cell line rich in SR-B1 receptors, this implies that the changes seen in this study were mediated largely by the SR-B1 pathway.
机译:替勃龙是用于治疗更年期症状和预防骨质疏松症的合成类固醇,但由于替勃龙可降低高密度脂蛋白(HDL)水平,因此对心血管系统的作用尚不清楚。我们调查了在食蟹猴中长期使用替勃龙或常规激素替代疗法(HRT)治疗是否会影响其血清胆固醇外流潜能。绝经后食蟹猕猴的手术用共轭马雌激素(CEE),CEE加醋酸甲羟孕酮(MPA),小剂量替勃龙或大剂量替勃龙治疗2年。在研究期间监测血浆脂质,脂蛋白和载脂蛋白水平。在培养物中的(3)H-胆固醇标记的Fu5AH细胞和皮肤成纤维细胞中测定每只动物的血清的胆固醇外排潜能。替勃龙可诱导HDL剂量依赖性降低30%至52%。如女性所见,当HDL浓度降低30%时,Fu5AH细胞的血清胆固醇外排潜能没有降低。 HDL降低52%,胆固醇外流降低14%。尽管CEE或CEE + MPA对HDL水平无明显影响,但CEE治疗可使血清胆固醇外流潜力增加7%。在相同的血清中,成纤维细胞未观察到胆固醇外流的变化。尽管我们的发现表明HDL浓度与血清胆固醇外排潜力相关,但这种关系很弱,仅解释了16%的变异性。尽管替替龙使HDL降低了30%,但没有迹象表明对细胞胆固醇外排有不利影响。这项研究中未测量的血清中的其他变化必须显着促进血清中胆固醇的外流。因为仅在富含SR-B1受体的细胞系Fu5AH细胞中观察到了血清胆固醇外流潜能的变化,这表明本研究中观察到的变化主要是由SR-B1途径介导的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号